ResearchMoz

Dialysis Partnering 2007-2013

Current Partnering
Published Date » 2013-07-01
No. Of Pages » 100
   
 The Dialysis Partnering  2007-2013 provides understanding and access to the dialysis partnering deals and agreements entered into by the worlds leading healthcare companies. 
   
 The report provides an analysis of dialysis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors dialysis technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. 
   
 Understanding the flexibility of a prospective partners negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of...
Table of Content

Executive Summary

Chapter 1 Introduction

Chapter 2 Trends in dialysis partnering
2.1. Introduction
2.2. Dialysis partnering over the years
2.3. Bigpharma dialysis dealmaking activity
2.4. Dialysis partnering by deal type
2.5. Dialysis partnering industry sector
2.6. Dialysis partnering by stage of development
2.7. Dialysis partnering by technology type
2.8. Disclosed financial deal terms for dialysis partnering
2.8.1 Dialysis headline values
2.8.2 Dialysis upfront payments
2.8.3 Dialysis milestone payments
2.8.4 Dialysis royalty rates

Chapter 3 Leading dialysis deals
3.1. Introduction
3.2. Top dialysis deals by value
3.3. Top dialysis deals involving bigpharma

Chapter 4 Dealmaking directory
4.1. Introduction
4.2. Company A-Z
4.3. By deal type
Asset purchase
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Contract service
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Manufacturing
Marketing
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Termination
4.4. By industry sector
Academic
Bigpharma
Biotech
Drug delivery
Medical device
Diagnostic
Generic pharma
Government
Non-profit
Pharmaceutical
Research tools
Services
Specialty pharma
4.5. By stage of development
Discovery
Pre-clinical
Phase I
Phase II
Phase III
Registration
Marketed
4.6. By technology type
Analysis
Animal models
Assays
Bioinformatics
Biological compounds
Biomarkers
Biomaterials
Cell culture
Cell therapy
Clinical testing
Diagnostic - companion
Devices
Diagnostics
Discovery tools
DNA probes
Drug delivery
Enabling technology
Epigenetics
Equipment
Facilities
Gene therapy
Genomics
Imaging
Industrial chemicals
In vitro models
Monoclonal antibodies
Nanotechnology
Oligonucleotide
Peptides
Personalised medicine
Processes
Proteomics
Radio/Chemo-therapy
Recombinant DNA
Research services
Research supplies
RNA therapeutics
Screening
Small molecules
Stem cells
Vaccines

Chapter 5 Partnering resource center
5.1. Online partnering
5.2. Partnering events
5.3. Further reading on dealmaking

Appendices

Appendix 1 Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent titles from CurrentPartnering
Order Form Reports

List of Tables

NA

List of Figures


Figure 1: Dialysis partnering since 2007 
Figure 2: Bigpharma top 50 dialysis deals 2007 to 2011 
Figure 3: Bigpharma dialysis deal frequency 2007 to 2011 
Figure 4: Dialysis partnering by deal type since 2007 
Figure 5: Dialysis partnering by industry sector since 2007 
Figure 6: Dialysis partnering by stage of development since 2007 
Figure 7: Dialysis partnering by technology type since 2007 
Figure 8: Dialysis deals with a headline value 
Figure 9: Dialysis deals with upfront payment values 
Figure 10: Dialysis deals with milestone payments 
Figure 11: Dialysis deals with royalty rates, % 
Figure 12: Top dialysis deals by value since 2007 
Figure 13: Top dialysis deals signed by bigpharma value since 2007 
Figure 14: Online partnering resources 
Figure 15: Forthcoming partnering events 
Figure 16: Deal type definitions

Upcoming Reports:

Direct Methanol Fuel Cell Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Direct methanol fuel cells provide extended run times with quick refill of charging liquid. These cells are expected to equal the cost with thin film batteries by the end of the forecasted period. Increasing demand for portable electricity with increasing use of broadband cell phones, laptops, and tablet PCs is mainly driving the DMFC market. Global market for direct methanol fuel cell (DMFC) is expected to reach 92,000 units by 2016 at an estimated growth rate of 45.3%. This tremendous growth in the DMFC market is expected as a result of the new generation of portable...
Sulfur Dyes Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Sulfur dyes are high molecular weight compounds that are obtained from the reaction of sulfur or sulfides with phenols and amines. There are many colorants available in the market that contain sulfur however, only those dyes that are soluble in water after reacting with sodium sulphide in alkaline conditions are known to be sulfur dyes. The exact chemical structure of sulfur dyes are not known as the molecules of sulfur dyes are highly complex in nature. Amino derivatives, nitro, aminobiphenyls, nitrobenzenes, substituted naphthalenes, indophenols, azines and oxazine among others can be...
Greece: market of fresh, chilled and frozen pig meat
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the fresh, chilled and frozen pig meat market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the fresh, chilled and frozen pig meat market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...
Fresh Lawsuits Hit General Motors
Jul 30, 2014  
This Tuesday, a lawsuit has hit General Motors on behalf of nearly 650 people regarding the faulty ignition switches in a number of cars, the reason why these cars were recalled from customers, which led to accidents that injured and even killed people.  The lawsuit was filed in the federal court of Manhattan, where dozens of cases against the company over the issue of faulty ignition...
Export market in New Zealand driven by innovative and high-value food products
Jul 29, 2014  
Demand for beverages and high value foods in Asia are driving the food and beverage industry in New Zealand. Also there is high demand for dairy products, seafood, meat and processed foods in the Asian economies which fuel the give an export boost to the economy of New Zealand.  Asia has a rapidly growing market for food which in turn is highly beneficial for New Zealand’s export...